Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy.

PURPOSE Since clinically significant upgrading of the biopsy Gleason score has an adverse clinical impact, ancillary tools besides the visual determination of primary Gleason pattern are essential to aid in better risk stratification. MATERIALS AND METHODS A total of 61 prostate biopsies were selected in patients with a diagnosis of Gleason score 7 prostatic adenocarcinoma, including 41 with primary Gleason pattern 3 and 20 with primary Gleason pattern 4. Slides from these tissues were stained using Feulgen stain, a nuclear DNA stain. Areas of Gleason pattern in all cases were analyzed for 40 nuclear morphometric descriptors of size, shape and chromatin using a CAS-200 system (BD). The primary outcome analyzed was the ability of morphometric features to identify visually determined primary Gleason pattern 4 on the biopsy. Data were analyzed using logistic regression as well as a C4.5 decision tree with and without preselection. RESULTS Decision tree analysis yielded the best model. Automatic feature selection identified minimum nuclear diameter as the most discriminative feature in a 3-parameter model with 85% classification accuracy. Using a preselected 3-parameter model including minimum diameter, angularity and sum optical density the decision tree yielded a slightly lesser accuracy of around 79%. Bootstrap validation of logistic regression results revealed that there was no unique model that could significantly explain the variance in primary Gleason pattern status, although minimum nuclear diameter was the most frequently selected parameter. CONCLUSIONS In this small cohort of patients with Gleason score 7 disease we report that Gleason pattern 4 nuclei from those with primary Gleason pattern 4 are generally larger with coarser chromatin compared with the Gleason pattern 4 in patients with primary Gleason pattern 3. These findings may aid in better risk stratification of the Gleason score 7 group by supplementing visual estimation of the percent of primary Gleason pattern 3 and 4 in the biopsy.

[1]  Christopher R King,et al.  Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. , 2004, International journal of radiation oncology, biology, physics.

[2]  A. Evans,et al.  Clinical predictors of gleason score upgrading , 2007, Cancer.

[3]  Jonathan A. Cooper,et al.  Role of epidermal growth factor‐stimulated protein kinase in control of proliferation of A431 cells , 1982, Journal of cellular biochemistry.

[4]  B. Leibovich,et al.  Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. , 2006, The Journal of urology.

[5]  J. Ross Quinlan,et al.  C4.5: Programs for Machine Learning , 1992 .

[6]  R. Veltri,et al.  The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis. , 1998, Seminars in urologic oncology.

[7]  J. Sinacore,et al.  Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning , 2006, Virchows Archiv.

[8]  R W Veltri,et al.  Quantitative nuclear grade (QNG): A new image analysis‐based biomarker of clinically relevant nuclear structure alterations , 2000, Journal of cellular biochemistry. Supplement.

[9]  A. Hanlon,et al.  A gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy , 1998, Cancer.

[10]  C. King,et al.  Prostate biopsy grading errors: A sampling problem? , 2000, International journal of cancer.

[11]  T. Mattfeldt,et al.  Classification of prostatic carcinoma with artificial neural networks using comparative genomic hybridization and quantitative stereological data. , 2003, Pathology, research and practice.

[12]  M. Terris,et al.  Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. , 2006, Urology.

[13]  A. Partin,et al.  Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer. , 2006, Urology.

[14]  B. Trock,et al.  Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. , 2006, Urology.

[15]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[16]  M. Banerjee,et al.  Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. , 2000, Urology.

[17]  J. Epstein,et al.  A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score. , 2008, The Journal of urology.

[18]  A. Partin,et al.  Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis , 2007, The Prostate.